Search results
Showing 6316 to 6330 of 8905 results
New age-based blood test thresholds recommended by NICE will help GPs catch ovarian cancer earlier
More women with ovarian cancer could be diagnosed earlier under proposed new NICE guidance that replaces a one-size-fits-all blood test threshold with personalised, age-based criteria.
NICE recommends new treatment option for highly active multiple sclerosis
Thousands of people living with a form of multiple sclerosis (MS) will benefit from greater treatment choice, following new guidance from NICE.
NICE announces Professor Jonathan Benger as new Chief Executive
NICE Chairman, Sharmila Nebhrajani, today announced Professor Jonathan Benger CBE as incoming chief executive, with effect from Friday 19 December 2025 taking over from Dr Samantha Roberts.
Discontinued Reference number: GID-TA10474
Lenalidomide with R-CHOP for untreated activated diffuse large B-cell lymphoma [ID1611]
Discontinued Reference number: GID-TA10480
In development Reference number: GID-TA10483 Expected publication date: TBC
Discontinued Reference number: GID-TA10484
ERC1671 for treating progressed or recurrent grade IV glioma (glioblastoma or gliosarcoma) [ID1623]
In development Reference number: GID-TA10489 Expected publication date: TBC
Discontinued Reference number: GID-TA10490
Discontinued Reference number: GID-TA10492
Idasanutlin with cytarabine for treating relapsed or refractory acute myeloid leukaemia [ID1597]
Discontinued Reference number: GID-TA10494
Discontinued Reference number: GID-TA10495
Discontinued Reference number: GID-TA10499
Discontinued Reference number: GID-TA10512
Inebilizumab for treating neuromyelitis optica spectrum disorders [ID1529]
Discontinued Reference number: GID-TA10522